BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Reports Second Quarter 2026 Financial Results and Corporate Updates
ENANTA PHARMACEUTICALS INC (ENTA)
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026
SILENCE THERAPEUTICS PLC (SLN)
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
MESA LABORATORIES INC /CO/ (MLAB)
Mesa Labs Announces First Quarter Results
IN8BIO, INC. (INAB)
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ALPHA TAU MEDICAL LTD. (DRTS)
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update
INSPIREMD, INC. (NSPR)
InspireMD to Announce Second Quarter 2026 Financial Results
SEPTERNA, INC. (SEPN)
Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results
OPERA LTD (OPRA)
Opera to Report Q2 2026 Financial Results Ahead of Schedule on August 19, 2026
NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)
NIQ Announces Strong Second Quarter 2026 Results